Efficacy and Safety of StENt-assisted treatment for CErebral aneurysms
Phase 4
- Conditions
- Intracranial aneurysm
- Registration Number
- JPRN-UMIN000009179
- Lead Sponsor
- Translational Research Informatics, Foundation for Biomedical Research and Innovation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
not decided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method death, stroke and hemorrhagic event within 2-years after treatment
- Secondary Outcome Measures
Name Time Method 1. death, stroke, hemorrhagic event within 30days or between 31days to 2years after treatment 2. any change of anti-thrombotic therapy within 2years after treatment 3. recanalization or re-treatment within 2years after treatment 4. stent stenosis or occlusion within 2years after treatment 5. any adverse event within 2years after treatment